T. Fagan

Most-cited papers

The cardiovascular dysmetabolic syndrome.
T. Fagan, Prakash C. Deedwania
1998American Journal of Medicine142 citations
Semantic Scholar
The predictable relationship between plasma levels and dose during chronic propranolol therapy
T. Walle, E. Conradi, U. Walle, T. Fagan +1 more
1978Clinical pharmacology and therapy121 citations
Semantic Scholar
Postprandial alterations in hemodynamics and blood pressure in normal subjects.
T. Fagan, P. Sawyer, L. Gourley, Jonetta T. Lee +1 more
1986American Journal of Cardiology118 citations
Semantic Scholar
Effects of ketorolac tromethamine on hemostasis in volunteers
K. Conrad, T. Fagan, M. Mackie, Paula V. Mayshar
1988Clinical pharmacology and therapy110 citations
Semantic Scholar
Clinical review of histamine2 receptor antagonists.
Robert J. Lipsy, Brian Fennerty, T. Fagan
1990Archives of Internal Medicine93 citations
Semantic Scholar
Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy.
T. Fagan, James R. Sowers
1999Archives of Internal Medicine85 citations
Semantic Scholar
Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
J. Neutel, David H. G. Smith, C. S. Ram, N. Kaplan +5 more
1993American Journal of Medicine82 citations
Semantic Scholar
4‐Hydroxypropranolol and its glucuronide after single and long‐term doses of propranolol
T. Walle, E. Conradi, U. Walle, T. Fagan +1 more
1980Clinical pharmacology and therapy78 citations
Semantic Scholar
Stereoselective ring oxidation of propranolol in man.
T. Walle, U. Walle, M. Wilson, T. Fagan +1 more
1984British Journal of Clinical Pharmacology75 citations Open access
Semantic Scholar
Presystemic and systemic glucuronidation of propranolol
T. Walle, T. Fagan, E. Conradi, U. Walle +1 more
1979Clinical pharmacology and therapy65 citations
Semantic Scholar
Increased clearance of propranolol and theophylline by high‐protein compared with high‐carbohydrate diet
T. Fagan, T. Walle, Mary Joan Oexmann, U. Walle +2 more
1987Clinical pharmacology and therapy63 citations
Semantic Scholar
Valsartan/Hydrochlorothiazide is Effective in Hypertensive Patients Inadequately Controlled by Valsartan Monotherapy
J. Mallion, R. Carretta, P. Trenkwalder, JEAN-FELIPE Martinez +4 more
2003Blood pressure. Supplement62 citations Open access
Semantic Scholar
Food‐induced increase in propranolol bioavailability—Relationship to protein and effects on metabolites
T. Walle, T. Fagan, U. Walle, M. Oexmann +2 more
1981Clinical pharmacology and therapy56 citations
Semantic Scholar
Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension.
S. Chrysant, T. Fagan, R. Glazer, A. Kriegman
1996Archives of Family Medicine55 citations
Semantic Scholar
Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
S. Butman, J. Wild, P. Nolan, T. Fagan +4 more
1991The Journal of Heart and Lung Transplantation51 citations
Semantic Scholar
Propranolol glucuronide cumulation during long‐term propranolol therapy: A proposed storage mechanism for propranolol
T. Walle, E. Conradi, U. Walle, T. Fagan +1 more
1979Clinical pharmacology and therapy49 citations
Semantic Scholar
Remembering the lessons of basic pharmacology.
T. Fagan
1994Archives of Internal Medicine48 citations
Semantic Scholar
Effects of meals on hemodynamics: Implications for antihypertensive drug studies
T. Fagan, K. Conrad, J. Mar, L. Nelson
1986Clinical pharmacology and therapy43 citations
Semantic Scholar
Levodopa Positively Affects Neovascular Age-Related Macular Degeneration
Anna G. Figueroa, Brennan M. Boyd, C. Christensen, Cameron G. Javid +3 more
2020American Journal of Medicine41 citations Open access
Semantic Scholar
Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates.
T. Fagan, S. Buttler, T. C. Marbury, Addison A. Taylor +1 more
2001American Journal of Cardiology37 citations
Semantic Scholar
Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
D. T. Lowenthal, S. Saris, E. Paran, N. Cristal +3 more
1986American Heart Journal37 citations
Semantic Scholar
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
G. Bakris, D. Sica, V. Ram, T. Fagan +2 more
2002American Journal of Hypertension36 citations Open access
Semantic Scholar
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.
U. Walle, T. Fagan, M. Topmiller, E. Conradi +1 more
1994British Journal of Clinical Pharmacology35 citations Open access
Semantic Scholar
Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
M. Reif, William B. White, T. Fagan, S. Oparil +4 more
1998American Journal of Cardiology34 citations
Semantic Scholar
Acute reduction of blood pressure in asymptomatic patients with severe hypertension. An idea whose time has come--and gone.
T. Fagan
1989Archives of Internal Medicine30 citations
Semantic Scholar
Single versus triplicate measurements of blood pressure and heart rate.
T. Fagan, K. Conrad, P. Mayshar, M. Mackie +1 more
1988HYPERTENSION30 citations Open access
Semantic Scholar
Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women.
T. Walle, T. Fagan, U. Walle, M. Topmiller
2003British Journal of Clinical Pharmacology26 citations Open access
Semantic Scholar
Naphthoxylactic acid after single and long‐term doses of propranolol
T. Walle, E. Conradi, U. Walle, T. Fagan +1 more
1979Clinical pharmacology and therapy25 citations
Semantic Scholar
Effects of high protein, high carbohydrate, and high fat diets on laboratory parameters.
T. Fagan, M. Oexmann
1987Journal of the American College of Nutrition17 citations
Semantic Scholar
Efficacy and Safety Comparison of Nitrendipine and Hydralazine as Antihypertensive Monotherapy
T. Fagan, Cheryl Sternleib, Nicolas D. Vlachakis, Prakash C. Deedwania +1 more
1984Journal of Cardiovascular Pharmacology16 citations Open access
Semantic Scholar
Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
T. Fagan, B. Haggert, C. Liss
1994Clinical Therapeutics13 citations
Semantic Scholar
Evolution of the Joint National Committee reports, 1988-1997. Evolution of the science of treating hypertension.
T. Fagan
1997Archives of Internal Medicine12 citations
Semantic Scholar
Similar efficacy of nitrendipine in young and elderly hypertensive patients.
Jawahar L. Mehta, Larry M. Lopez, Prakash C. Deedwania, T. Fagan +4 more
1987American Journal of Cardiology12 citations
Semantic Scholar
Early kinetics of intravenous propranolol.
T. Fagan, T. Walle, U. Walle, E. Conradi +2 more
1982British Journal of Clinical Pharmacology12 citations Open access
Semantic Scholar
Nicardipine and hydrochlorothiazide in essential hypertension
T. Fagan, Ronald T. Brown, H. Schnaper, P. Smolens +5 more
1989Clinical pharmacology and therapy10 citations
Semantic Scholar
Once‐ and Twice‐daily Nitrendipine in Patients with Hypertension and Noninsulin‐dependent Diabetes
T. Fagan, Edward B. Nelson, K. Lasseter, J. Crook +2 more
1986Pharmacotherapy9 citations
Semantic Scholar
Metronidazole-lnduced Gynecomastia
T. Fagan, David G. Johnson, D. Grosso
19859 citations
Semantic Scholar
Time course of development of the antihypertensive effect of propranolol.
T. Fagan, T. Walle, Rebecca Corns-Hurwitz, Edward C. Conradi +4 more
1983HYPERTENSION9 citations Open access
Semantic Scholar
Antihypertensive effects of lofexidine in patients with essential hypertension.
T. Fagan, S. Bloomfield, T. Cowart, RH Corns-Hurwitz +8 more
1982British Journal of Clinical Pharmacology9 citations Open access
Semantic Scholar
Doxazosin in patients with hypertension
K. Conrad, T. Fagan, M. Mackie, Paula V. Mayshar +4 more
2004European Journal of Clinical Pharmacology8 citations
Semantic Scholar
Acute hypotensive effects of oral and intravenous propranolol: early alterations in peripheral resistance.
T. Fagan, L. Gourley, P. Sawyer, J. T. Lee +2 more
1986The Journal of Clinical Hypertension8 citations
Semantic Scholar
Calcium antagonists and mortality. Another case of the need for clinical judgment.
T. Fagan
1995Archives of Internal Medicine7 citations
Semantic Scholar
Pulse Pressure Responses in Patients Treated with Valsartan and Hydrochlorothiazide Combination Therapy
R. Carretta, P. Trenkwalder, F. Martínez, A. Tykarski +4 more
2003Journal of International Medical Research6 citations
Semantic Scholar
Sustained-release nicardipine in mild-to-moderate hypertension.
T. Fagan, Elizabeth D. Tyler, Martha A. Reitman, Susan Kenley +1 more
1993Chest6 citations
Semantic Scholar
Antihypertensive effects of parenteral nicardipine alone and in combination with captopril
K. Conrad, T. Fagan, P. Mayshar, Thomas P. Davis +1 more
1987Clinical pharmacology and therapy6 citations
Semantic Scholar
Blood Pressure Reduction and Tolerability of Felodipine ER in Older and Younger Hypertensive Patients
T. Fagan
19975 citations
Semantic Scholar
Diltiazem: Its Place in the Antihypertensive Armamentarium
T. Fagan
1991Journal of Cardiovascular Pharmacology5 citations Open access
Semantic Scholar
Metronidazole-induced gynecomastia.
T. Fagan, David G. Johnson, David S. Grosso
1985Journal of the American Medical Association (JAMA)5 citations
Semantic Scholar
Treatment of Mild Hypertension with Low Once‐Daily Doses of a Sustained‐Release Capsule Formulation of Verapamil
P. J. Davis, T. Fagan, M. Topmiller, J. Levine +1 more
1995Journal of clinical pharmacology4 citations
Semantic Scholar
Effect of tripamide on glucose tolerance in patients with hypertension
K. Conrad, T. Fagan, Stanley M. Lee, J. Simons
1986Clinical pharmacology and therapy4 citations
Semantic Scholar